Targeted prostate cancer screening programme to be rolled out in England from 2027

The UK Government has pledged to introduce targeted prostate cancer screening programme in England and will also invest up to £18 million in the TRANSFORM trial. This means that men in England at greatest risk - those who are 45 to 61-years-old with both a BRCA2 gene change and a family history of breast, ovarian, pancreatic or prostate cancer -…